Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin-induced reductions in tumor growth involves modulation of the gut microbiome
Lindsay A. Broadfield, Amna Saigal, Jake C. Szamosi, et al.
Molecular Metabolism (2022) Vol. 61, pp. 101498-101498
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

New insights into activation and function of the AMPK
Gregory R. Steinberg, D. Grahame Hardie
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 4, pp. 255-272
Closed Access | Times Cited: 475
Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 324
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
Simon Lord, Adrian L. Harris
British Journal of Cancer (2023) Vol. 128, Iss. 6, pp. 958-966
Open Access | Times Cited: 80
Human trials exploring anti-aging medicines
Leonard Guarente, David Sinclair, Guido Kroemer
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 354-376
Open Access | Times Cited: 69
Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases
Hamid M. Abdolmaleky, Jin‐Rong Zhou
Antioxidants (2024) Vol. 13, Iss. 8, pp. 985-985
Open Access | Times Cited: 40
Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 302-302
Open Access | Times Cited: 16
Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study
Yang Du, Yajuan Zhu, Yixin Zhou, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 40
Potential links between the microbiota and T cell immunity determine the tumor cell fate
Amir Hossein Mohseni, Sedigheh Taghinezhad‐S, Vincenzo Casolaro, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 23
Understanding the action mechanisms of metformin in the gastrointestinal tract
Meihui Cheng, Lili Ren, Xianxian Jia, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 14
Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer
Tuoyu Zhou, Jingyuan Wu, Haibo Tang, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma
Jiaqi Sun, Jun Ding, Qingsong Shen, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 627-642
Closed Access | Times Cited: 29
Western diet influences on microbiome and carcinogenesis
Rachel C. Newsome, Ye Yang, Christian Jobin
Seminars in Immunology (2023) Vol. 67, pp. 101756-101756
Open Access | Times Cited: 16
Sodium butyrate facilitates CRHR2 expression to alleviate HPA axis hyperactivity in autism-like rats induced by prenatal lipopolysaccharides through histone deacetylase inhibition
Xinyuan Wang, Zhujun Sun, Ting Yang, et al.
mSystems (2023)
Open Access | Times Cited: 14
METFORMIN: FROM DIABETES TO CANCER TO PROLONGATION OF LIFE
Cesare R. Sirtori, Sofia Castiglione, Chiara Pavanello
Pharmacological Research (2024) Vol. 208, pp. 107367-107367
Open Access | Times Cited: 5
Protective Effects of Imeglimin and Metformin Combination Therapy on β-Cells in db/db Male Mice
Kuniyuki Nishiyama, Masato Ono, Takahiro Tsuno, et al.
Endocrinology (2023) Vol. 164, Iss. 8
Open Access | Times Cited: 12
A neutral polysaccharide from Persicaria hydropiper (L.) Spach ameliorates lipopolysaccharide-induced intestinal barrier injury via regulating the gut microbiota and modulating AKT/PI3K/mTOR and MAPK signaling pathways
Xuanxuan Cheng, Yuehua Zhu, Jiahuan Huang, et al.
Journal of Ethnopharmacology (2023) Vol. 320, pp. 117403-117403
Closed Access | Times Cited: 11
A Narrative Review: Repurposing Metformin as a Potential Therapeutic Agent for Oral Cancer
Jui-Hsiang Li, Pei-Yi Hsin, Yung-Chia Hsiao, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3017-3017
Open Access | Times Cited: 4
Fecal Microbiota Transplantation, a tool to transfer healthy longevity
Marta G. Novelle, Beatriz Naranjo-Martínez, Juan L López-Cánovas, et al.
Ageing Research Reviews (2024) Vol. 103, pp. 102585-102585
Open Access | Times Cited: 4
Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice
Xinmeng Wang, Qian Geng, Hua Jiang, et al.
BMC Immunology (2025) Vol. 26, Iss. 1
Open Access
Metformin in the prevention and treatment of colorectal cancer
І.А. Нromakova, П.П. Сорочан, N. E. Prokhach, et al.
Український радіологічний та онкологічний журнал (2025) Vol. 33, Iss. 1, pp. 82-99
Open Access
Association of metformin and statin uses with the prognosis of colon cancer: a meta-analysis
Yanyan Xu, Hao Che, Jiang Liu, et al.
European Journal of Cancer Prevention (2024) Vol. 33, Iss. 5, pp. 414-424
Closed Access | Times Cited: 3
Short-chain fatty acids play a positive role in colorectal cancer
Gang Liu, Jingtong Tang, Jianping Zhou, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Targeting the gut microbiota: a new strategy for colorectal cancer treatment
Yue Hu, Peng Zhou, Kaili Deng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Effect of carotenoids on gut health and inflammatory status: A systematic review of in vivo animal studies
Talitha Silva Meneguelli, Marcella Duarte Villas Mishima, Helen Hermana Miranda Hermsdorff, et al.
Critical Reviews in Food Science and Nutrition (2023) Vol. 64, Iss. 30, pp. 11206-11221
Closed Access | Times Cited: 8
Current status and frontier tracking of clinical trials on Metformin for cancer treatment
Zhipeng Wu, Wei Wang, Lengyun Wei, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 18, pp. 16931-16946
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top